- Home
- ENVA vs VKTX Comparison
ENVA vs VKTX Comparison
Compare ENVA & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENVA | VKTX |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.5B |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ENVA | VKTX |
|---|---|---|
| Price | $170.83 | $28.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 21 |
| Target Price | ★ $230.83 | $95.32 |
| AVG Volume (30 Days) | 310.0K | ★ 4.3M |
| Earning Date | 10-22-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.05 | N/A |
| EPS | ★ 11.49 | N/A |
| Revenue | ★ $3,151,653,000.00 | N/A |
| Revenue This Year | $159.48 | N/A |
| Revenue Next Year | $19.84 | N/A |
| P/E Ratio | $14.74 | ★ N/A |
| Revenue Growth | ★ 18.58 | N/A |
| 52 Week Low | $119.02 | $23.82 |
| 52 Week High | $267.45 | $43.10 |
Technical Indicators
Market Signals| Indicator | ENVA | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 53.44 |
| Support Level | $163.41 | $26.47 |
| Resistance Level | $179.70 | $34.00 |
| Average True Range (ATR) | 7.68 | 1.67 |
| MACD | 0.22 | 0.56 |
| Stochastic Oscillator | 35.88 | 77.31 |
Price Performance
Historical ComparisonAbout ENVA Enova International Inc.
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.